Mikko P. Laakso

Mikko P. Laakso

Auto-generated profile, based on publicly available information

Mikko P. Laakso

Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2001 in BMJ
Verified
Journal Article
Open access
PDF file
MKMiia Kivipelto
Miia Kivipelto
EHEeva-Liisa Helkala
Eeva-Liisa Helkala
MLMikko P Laakso
Mikko P Laakso
THTuomo Hänninen
Tuomo Hänninen
MHMerja Hallikainen
Merja Hallikainen
ANAulikki Nissinen
Aulikki Nissinen
Objective: To examine the relation of midlife raised blood pressure and serum cholesterol concentrations to Alzheimer's disease in later life. Design: Prospective, population based study. Setting: Populations of Kuopio and Joensuu, eastern Finland. Participants: Participants were derived from random, population based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average of 21 years' follow up, a total of 1449 (73%) participants aged 65–79 took part in the re-examination in 1998. Main outcome measures: Midlife blood pressure and cholesterol concentrations and development of Alzheimer's disease in later life. Results: People with raised systolic blood pressure (≥160 mm Hg) or high serum cholesterol concentration (≥6.5 mmol/l) in midlife had a significantly higher risk of Alzheimer's disease in later life, even after adjustment for age, body mass index, education, vascular events, smoking status, and alcohol consumption, than those with normal systolic blood pressure (odds ratio 2.3, 95% confidence interval 1.0 to 5.5) or serum cholesterol (odds ratio 2.1, 1.0 to 4.4). Participants with both of these risk factors in midlife had a significantly higher risk of developing Alzheimer's disease than those with either of the risk factors alone (odds ratio 3.5, 1.6 to 7.9). Diastolic blood pressure in midlife had no significant effect on the risk of Alzheimer's disease. Conclusion: Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increase the risk of Alzheimer's disease in later life. What is already known on this topic: Vascular risk factors may play an important part as risk factors for Alzheimer's disease No population based studies have evaluated prospectively the impact of both midlife blood pressure and cholesterol concentration in both men and women on the subsequent development of Alzheimer's disease What this study adds: Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increased the risk of Alzheimer's disease in later life Raised systolic blood pressure and hypercholesterolaemia may have a role in the pathogenesis of Alzheimer's disease; more emphasis should be placed on identification and appropriate treatment of these conditions

1 October 2001 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
ADA T Du
A T Du
NSN Schuff
N Schuff
DAD Amend
D Amend
MLM P Laakso
M P Laakso
YHY Y Hsu
Y Y Hsu
MWM W Weiner
M W Weiner
OBJECTIVES To explore volume changes of the entorhinal cortex (ERC) and hippocampus in mild cognitive impairment (MCI) and Alzheimer's disease (AD) compared with normal cognition (NC); to determine the powers of the ERC and the hippocampus for discrimination between these groups. METHODS This study included 40 subjects with NC, 36 patients with MCI, and 29 patients with AD. Volumes of the ERC and hippocampus were manually measured based on coronal T1 weighted MR images. Global cerebral changes were assessed using semiautomatic image segmentation. RESULTS Both ERC and hippocampal volumes were reduced in MCI (ERC 13%, hippocampus 11%, p<0.05) and AD (ERC 39%, hippocampus 27%, p<0.01) compared with NC. Furthermore, AD showed greater volume losses in the ERC than in the hippocampus (p<0.01). In addition, AD and MCI also had cortical grey matter loss (p< 0.01) and ventricular enlargement (p<0.01) when compared with NC. There was a significant correlation between ERC and hippocampal volumes in MCI and AD (both p<0.001), but not in NC. Using ERC and hippocampus together improved discrimination between AD and CN but did not improve discrimination between MCI and NC. The ERC was better than the hippocampus for distinguishing MCI from AD. In addition, loss of cortical grey matter significantly contributed to the hippocampus for discriminating MCI and AD from NC. CONCLUSIONS Volume reductions in the ERC and hippocampus may be early signs of AD pathology that can be measured using MRI.

26 June 2001 in Neurology
Verified
Journal Article
Closed access
PDF file
MKM. Kivipelto
M. Kivipelto
EHE.-L. Helkala
E.-L. Helkala
THT. Hänninen
T. Hänninen
MLM. P. Laakso
M. P. Laakso
MHM. Hallikainen
M. Hallikainen
ANA. Nissinen
A. Nissinen
Objective: To evaluate the impact of midlife elevated serum cholesterol levels and blood pressure on the subsequent development of mild cognitive impairment (MCI) and to investigate the prevalence of MCI in elderly Finnish population, applying the MCI criteria devised by the Mayo Clinic Alzheimer’s Disease Research Center. Background: MCI has been considered as a predictor of AD. Vascular risk factors may be important in the development of cognitive impairment and AD. However, the role of vascular risk factors in MCI and the prevalence of MCI still remain virtually unknown. Methods: Subjects were derived from random, population-based samples previously studied in surveys carried out in 1972, 1977, 1982, and 1987. After an average follow-up of 21 years, 1,449 subjects aged 65 to 79 years were reexamined in 1998. Results: Eighty-two subjects, 6.1% of the population (average age, 72 years) met the criteria for MCI. Midlife elevated serum cholesterol level (≥6.5 mmol/L) was a significant risk factor for MCI (OR, 1.9; 95% CI, 1.2 to 3.0, adjusted for age and body mass index); the effect of systolic blood pressure approached significance. Conclusion: Data point to a role for midlife vascular risk factors in the development of MCI in late life.

1 March 2004 in Neurobiology of Aging
Verified
Journal Article
Closed access
CPCorina Pennanen
Corina Pennanen
MKMiia Kivipelto
Miia Kivipelto
STSusanna Tuomainen
Susanna Tuomainen
PHPäivi Hartikainen
Päivi Hartikainen
THTuomo Hänninen
Tuomo Hänninen
HSHilkka Soininen
Hilkka Soininen

6 August 2002 in Annals of Internal Medicine
Verified
Journal Article
Closed access
MKMiia Kivipelto
Miia Kivipelto
EHEeva-Liisa Helkala
Eeva-Liisa Helkala
MLMikko P. Laakso
Mikko P. Laakso
THTuomo Hänninen
Tuomo Hänninen
MHMerja Hallikainen
Merja Hallikainen
HSHilkka Soininen
Hilkka Soininen
Read the full review for this F1000Prime recommended article: Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

1 March 1996 in Neurology
Verified
Journal Article
Closed access
MLM. P. Laakso
M. P. Laakso
KPK. Partanen
K. Partanen
PRP. Riekkinen
P. Riekkinen
MLM. Lehtovirta
M. Lehtovirta
EHE.-L. Helkala
E.-L. Helkala
HSH. Soininen
H. Soininen
Hippocampal atrophy detected by volumetric MRI is a sensitive feature of early Alzheimer's disease (AD), but there are no studies evaluating hippocampal atrophy by MR volumetry in other dementing diseases. We therefore compared hippocampal volumes in a total of 113 subjects: 50 patients with mild to moderate AD, 9 patients with vascular dementia (VaD), 12 patients with idiopathic Parkinson's disease (PD) without dementia, 8 patients with PD and dementia (PDD), and 34 elderly control subjects. Thin, coronal, contiguous images were obtained by a 1.5-T MR imager. All patient groups had significantly smaller volumes of the hippocampus compared with the control group. In the PDD group, the absolute volumes were even smaller than in the AD group. In the PD group, the volumes were diminished to a lesser but significant extent. The volumes in the VaD group varied: of nine patients, two had no atrophy, three had unilateral, and four had bilateral atrophy. We postulate that hippocampal atrophy does not seem to be a specific phenomenon of dementia in AD but also occurs in VaD and PDD, and even in PD when no dementia is present. However, coexistence of AD pathology in our PD and VaD patients cannot be ruled out. Further studies with access to neuropathologic data are needed.